Janak Padia

528 total citations
18 papers, 445 citations indexed

About

Janak Padia is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Janak Padia has authored 18 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Organic Chemistry. Recurrent topics in Janak Padia's work include Drug Transport and Resistance Mechanisms (4 papers), Cholesterol and Lipid Metabolism (4 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Janak Padia is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Cholesterol and Lipid Metabolism (4 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Janak Padia collaborates with scholars based in United States, Japan and United Kingdom. Janak Padia's co-authors include Bharat K. Trivedi, Kenneth A. Jacobson, Daniela Salvemini, Dilip K. Tosh, Louise Webdale, Nirmala Suman‐Chauhan, Mary E. LaMarca, Ellen Sidransky, Douglas S. Auld and James Inglese and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Journal of Medicinal Chemistry.

In The Last Decade

Janak Padia

18 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janak Padia United States 10 223 172 98 52 50 18 445
Pauline Bourbon United States 9 137 0.6× 97 0.6× 118 1.2× 44 0.8× 45 0.9× 12 339
Eva J. van Rooden Netherlands 11 233 1.0× 135 0.8× 31 0.3× 13 0.3× 33 0.7× 15 394
Shinmee Mah South Korea 9 369 1.7× 136 0.8× 40 0.4× 9 0.2× 58 1.2× 13 597
Sarah James United Kingdom 8 254 1.1× 99 0.6× 29 0.3× 24 0.5× 78 1.6× 10 372
Harald M. H. G. Albers Netherlands 11 519 2.3× 112 0.7× 76 0.8× 62 1.2× 207 4.1× 11 673
Muralikrishna Duvvuri United States 7 216 1.0× 35 0.2× 66 0.7× 71 1.4× 50 1.0× 8 372
Giuseppina La Sala Italy 12 250 1.1× 39 0.2× 24 0.2× 25 0.5× 36 0.7× 15 352
Xiucong Bao Hong Kong 12 618 2.8× 118 0.7× 47 0.5× 46 0.9× 40 0.8× 19 825
Anna Rolando United States 6 345 1.5× 108 0.6× 23 0.2× 9 0.2× 41 0.8× 6 556
Christopher Moxham United States 9 487 2.2× 153 0.9× 45 0.5× 8 0.2× 19 0.4× 15 734

Countries citing papers authored by Janak Padia

Since Specialization
Citations

This map shows the geographic impact of Janak Padia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janak Padia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janak Padia more than expected).

Fields of papers citing papers by Janak Padia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janak Padia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janak Padia. The network helps show where Janak Padia may publish in the future.

Co-authorship network of co-authors of Janak Padia

This figure shows the co-authorship network connecting the top 25 collaborators of Janak Padia. A scholar is included among the top collaborators of Janak Padia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janak Padia. Janak Padia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Padia, Janak, Liudmila Kulakova, Andrey Galkin, & Osnat Herzberg. (2020). Discovery and Preclinical Development of Antigiardiasis Fumagillol Derivatives. Antimicrobial Agents and Chemotherapy. 64(10). 6 indexed citations
2.
Tosh, Dilip K., Janak Padia, Daniela Salvemini, & Kenneth A. Jacobson. (2015). Efficient, large-scale synthesis and preclinical studies of MRS5698, a highly selective A3 adenosine receptor agonist that protects against chronic neuropathic pain. Purinergic Signalling. 11(3). 371–387. 45 indexed citations
3.
Soldi, Raffaella, Stephen Horrigan, Janak Padia, et al.. (2015). Design, Synthesis, and Biological Evaluation of a Series of Anthracene-9,10-dione Dioxime β-Catenin Pathway Inhibitors. Journal of Medicinal Chemistry. 58(15). 5854–5862. 20 indexed citations
4.
Manzano, Mark, Janak Padia, & Radhakrishnan Padmanabhan. (2014). Small Molecule Inhibitor Discovery for Dengue Virus Protease Using High-Throughput Screening. Methods in molecular biology. 1138. 331–344. 5 indexed citations
5.
Nagao, Rina, Eishi Ashihara, Shinya Kimura, et al.. (2011). Growth inhibition of imatinib-resistant CML cells with the T315I mutation and hypoxia-adaptation by AV65 – a novel Wnt/β-catenin signaling inhibitor. Cancer Letters. 312(1). 91–100. 18 indexed citations
6.
Yao, Hisayuki, Eishi Ashihara, Jeffrey Strovel, et al.. (2011). AV-65, a novel Wnt/β-catenin signal inhibitor, successfully suppresses progression of multiple myeloma in a mouse model. Blood Cancer Journal. 1(11). e43–e43. 42 indexed citations
7.
Nagao, Rina, Eishi Ashihara, Shinya Kimura, et al.. (2009). Inhibition of Wnt/β-Catenin Signaling by AV65 Treatment Caused Cell Cycle Arrest and Induced Caspase-Independent or -Dependent Apoptosis in CML Cells.. Blood. 114(22). 2184–2184. 2 indexed citations
8.
Zheng, Wei, Janak Padia, Daniel J. Urban, et al.. (2007). Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease. Proceedings of the National Academy of Sciences. 104(32). 13192–13197. 119 indexed citations
9.
Sexton, Karen E., Helen T. Lee, Mark A. Massa, et al.. (2003). Inhibitors of lipoprotein(a) assembly. Bioorganic & Medicinal Chemistry. 11(22). 4827–4845. 6 indexed citations
10.
Padia, Janak, Mark J. Field, Ken Meecham, et al.. (1998). Novel Nonpeptide CCK-B Antagonists:  Design and Development of Quinazolinone Derivatives as Potent, Selective, and Orally Active CCK-B Antagonists. Journal of Medicinal Chemistry. 41(7). 1042–1049. 77 indexed citations
11.
12.
Dayal, B., et al.. (1997). 7β-hydroxy bile alcohols: Facile synthesis and 2D 1H NMR studies of 5β-cholestane-3α,7β,12α,25-tetrol. Steroids. 62(5). 409–414. 9 indexed citations
13.
Padia, Janak, et al.. (1997). Design and synthesis of novel nonpeptide CCK-B receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 7(7). 805–810. 12 indexed citations
14.
Roark, W. Howard, Janak Padia, Gary L. Bolton, et al.. (1995). Bioisosterism in drug design: Identification of and structure-activity relationships in a series of glycine anilide ACAT inhibitors. Bioorganic & Medicinal Chemistry. 3(1). 29–39. 3 indexed citations
15.
16.
Padia, Janak, et al.. (1993). Synthesis and sar study of novel CCK-B antagonists. Bioorganic & Medicinal Chemistry Letters. 3(12). 2805–2810. 3 indexed citations
17.
18.
Dayal, B., et al.. (1990). Lithium hydroxide/aqueous methanol: mild reagent for the hydrolysis of bile acid methyl esters. Steroids. 55(5). 233–237. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pauline Bourbon Breakdown of academic impact, for papers by Eva J. van Rooden Breakdown of academic impact, for papers by Shinmee Mah Breakdown of academic impact, for papers by Sarah James Breakdown of academic impact, for papers by Harald M. H. G. Albers Breakdown of academic impact, for papers by Muralikrishna Duvvuri Breakdown of academic impact, for papers by Giuseppina La Sala Breakdown of academic impact, for papers by Xiucong Bao Breakdown of academic impact, for papers by Anna Rolando Breakdown of academic impact, for papers by Christopher Moxham
Rankless by CCL
2026